This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liu H, Ruan M, Wang H, Wang H, Li X, Song G. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy? Prostate Cancer Prostatic Dis. 2020;23:589–95. https://doi.org/10.1038/s41391-020-0260-0. PMID: 32719353
Checcucci E, Piramide F, Amparore D, De Cillis S, Granato S, Sica M, et al. Beyond the learning curve of prostate MRI/TRUS target fusion biopsy after more than 1000 procedures. Urology. 2021;155:39–45.
Wenzel M, Würnschimmel C, Chierigo F, Tian Z, Shariat SF, Terrone C, et al. Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients. Prostate 2021;81:1055–63.
Author information
Authors and Affiliations
Contributions
Design this study: DW, SR. Written manuscript: SR. Correct the grammar and words: DW.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ren, S., Wang, D. Re: Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?. Prostate Cancer Prostatic Dis 26, 432 (2023). https://doi.org/10.1038/s41391-021-00471-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41391-021-00471-9